OTC Healthcare - France
OTC Healthcare in France : Market Insight
EXECUTIVE SUMMARY
Slow Growth De-reimbursement Limited Impact Pharmacies Stronghold Lessening Changing Mentalities Potential Growth KEY TRENDS AND DEVELOPMENTS
OTC Products in Difficult Trading Conditions Demographic Trends Impact Demand De-reimbursement: Does it Work? Economic Growth Increases Visits to Private Doctors Hectic Lifestyles and Rising Health Awareness Drive Sales MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Advertising Packaging and Labelling Distribution De-listing or De-reimbursement Vitamins and Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - France
Arkopharma SA, Laboratoires Pharmaceutiques - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 2 Arkopharma SA, Laboratoires Pharmaceutiques: Key Facts
Summary 3 Arkopharma SA, Laboratoires Pharmaceutiques: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 Arkopharma SA, Laboratoires Pharmaceutiques: Competitive Position 2006
Beaufour-Ipsen SA - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 5 Beaufour-Ipsen SA: Key Facts
Summary 6 Beaufour-Ipsen SA: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION
Summary 7 Beaufour-Ipsen SA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Beaufour-Ipsen SA: Competitive Position 2006
Juva Sant, Laboratoires - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 9 Juva Sant, Laboratoires: Key Facts
Summary 10 Juva Sant, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION
Summary 11 Juva Sant, Laboratoires: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 12 Juva Sant, Laboratoires: Competitive Position 2006
Laboratoires Martin-Johnson & Johnson-MSD SAS - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 13 Laboratoires Martin-Johnson & Johnson-MSD SAS: Key Facts
Summary 14 Laboratoires Martin-Johnson & Johnson-MSD SAS: Operational Indicators 2004-2006
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 15 Laboratoires Martin-Johnson & Johnson-MSD SAS: Competitive Position 2006
Pfizer Sant Grand Public - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 16 Pfizer Sant Grand Public: Key Facts
Summary 17 Pfizer Sant Grand Public: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 18 Pfizer Sant Grand Public: Competitive Position 2006
Pierre Fabre SA, Laboratoires - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 19 Pierre Fabre SA, Laboratoires: Key Facts
Summary 20 Pierre Fabre SA, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION
Summary 21 Pierre Fabre SA, Laboratoires: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 22 Pierre Fabre SA, Laboratoires: Competitive Position 2006
Thraplix SA - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 23 Thraplix SA: Key Facts
Summary 24 Thraplix SA: Operational Indicators 2004-2006
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 25 Thraplix SA: Competitive Position 2006
UPSA, Laboratoires - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 26 UPSA Conseil SAS: Key Facts
Summary 27 UPSA Conseil SAS: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 28 UPSA, Laboratoires: Competitive Position 2006
Urgo, Laboratoires - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 29 Urgo, Laboratoires: Key Facts
Summary 30 Urgo, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 31 Urgo, Laboratoires: Competitive Position 2006
Cough, cold and allergy (hay fever) remedies in France
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 14 Sales of Decongestants by Type: Value 2001-2006
Table 15 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 18 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
